trial

Future Mental Projections in Schizophrenia

NCTId NCT03040505
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Terminated
Enrollment 56 (actual)
Sponsored by University Hospital, Strasbourg, France
Primary completion 2019-10-20
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
56 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2017-04-05
Primary completion
2019-10-20
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
questionnary

Sponsors

University Hospital, Strasbourg, FranceLead Sponsor

Sites

1 total
Strasbourg, France

Facts & assertions

4 sourced
Enrollment
56
Phase
NA
Primary Completion Date
2019-10-20
Status
TERMINATED
relationships
The graph out of here
drug
questionnary
drug
lead_sponsor
University Hospital, Strasbourg, France
company
indication
Schizophrenia
indication
Schizophrenia
indication